Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0097-2023Class II

cobas 5800 instrument, Material No. 08707464001. Used for automated Polymerase Chain Reaction (PCR) based...

Roche Molecular Systems Inc / initiated 2022-09-08 / Terminated

Roche Molecular Systems, Inc. began a recall of cobas 5800 instrument, Material No. 08707464001. Used for automated Polymerase Chain Reaction (PCR) based Nucleic Acid Testing (NAT) in laboratory settings on . FDA classified it as Class II and gives the reason as "Reported false positive and invalid results on the affected devices due to anomalous baselines. This may lead to erroneous or delayed diagnoses". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-0097-2023
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Roche Molecular Systems Inc
Product
cobas 5800 instrument, Material No. 08707464001. Used for automated Polymerase Chain Reaction (PCR) based Nucleic Acid Testing (NAT) in laboratory settings.
Product code
NSU Instrumentation For Clinical Multiplex Test Systems
Reason for recall
Reported false positive and invalid results on the affected devices due to anomalous baselines. This may lead to erroneous or delayed diagnoses.
FDA root cause
Under Investigation by firm
Action
On September 8, 2022, the firm notified all affected customers via an Urgent Field Safety Notice letter. Customers were informed that the issue was attributed to WAKO lenses with a deposit on their surfaces, which can affect the signal in the detection unit. Roche will retrieve and analyze customer's cobas 5800 run data. If the evaluation determines that a lens cleaning is warranted, a service visit will be scheduled. If a lens cleaning is not warranted, no further actions are required. Customers should follow laboratory standard operating procedures to investigate the potential for false positive results for assays where a change in result reporting could impact patient management. In the case of testing for respiratory viruses or blood screening, uncovering false positive results more than one week old would be unlikely to change patient management. In the case of assays used to manage chronic diseases (e.g. hepatitis C) or those used in serial monitoring (e.g. HIV), only the most recent result for a patient would have the potential to affect management. Contact your local affiliate organization if there is any allegation of invalid or false positive results with the cobas 5800 system assays. This device is not currently available in the US.
Quantity in commerce
179 OUS
Distribution
International distribution in the countries of Austria, Belgium, Czech Republic, France, Germany, Greece, Ireland, Italy, Lithuania, Poland, Portugal, Spain, Sweden, Switzerland, UK, Chile, Colombia, Hong Kong, Jamaica, Japan, Nicaragua, Oman, Pakistan, UAE.
Product codes and lots
Device Identifier: 07613336170076 All serial IDs are affected.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0097-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0097-2023Class IITerminatedVoluntary: Firm initiated